Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED90 study of remimazolam combined with alfentanil for adult colonoscopy sedation
ChiCTR2200062835Phase 4Not yet recruiting
- Sponsor
- Traditional Chinese Medical Hospital of Zhuji
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam and alfentanil in None, sponsored by Traditional Chinese Medical Hospital of Zhuji. Primary endpoint: 90% effective dose of remimazolam combined with alfentanil in colonoscopy. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
remimazolamalfentanil
Beyond the preview
Go deeper on ChiCTR2200062835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062835.